Macroaxis: Personalized Investing
Simple Personalized Investing

S&P 500   1,667   17.00  Index Moved Up 1.03%
AODC BRH PC6A ICK Plastics Office Supplies Soft Drinks Raw Materials 
United States  USA  |  Company Directory


Processing
Collecting data for ^GSPC and CL ...

Asset Comparison and Correlation

    
Investment horizon: 
  30 Days    Login   to change
 
 S&P 500  vs   ColgatePalmolive Co.
Check Correlation Matrix  
Daily Returns (%)
GSPC   CL   
 
Assuming 30 trading days horizon, S&P 500 is expected to generate 0.05 times more return on investment than ColgatePalmo. However, S&P 500 is 19.96 times less risky than ColgatePalmo. It trades about 0.6 of its potential returns per unit of risk. ColgatePalmolive Co is currently generating about -0.2 per unit of risk. If you would invest  156,250  in S&P 500 on April 19, 2013 and sell it today you would earn a total of  10,497  from holding S&P 500 or generate 6.72% return on investment over 30 days.

Diversification

Weak diversification
Overlapping area represents amount of risk that can be diversified away by holding S&P 500 and ColgatePalmolive Co. in the same portfolio assuming nothing else is changed

Correlation Coefficient

0.39
Parameters
Time Period1 Month [change]
DirectionPositive CL Moved Up vs ^GSPC
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns
Follow Correlation between GSPC and CL with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Correlation between GSPC and CL to your reader
 
Share Correlation between GSPC and CL 
Find Opportunities
 
Predicted Return Density
 
Returns   
GSPC   CL   

S&P 500

 
    
SP 500
Performance
33
Out Of
100
Over 30
Days
    

Match ups for SP 500

Erickson AirCrane Incorporated vs. S&P 500
Vanguard TaxManaged Intl Adm vs. S&P 500
Vanguard TaxManaged Small Cap Adm vs. S&P 500
Opko Health Inc vs. S&P 500
Vanguard Emerging Mkts Stock Idx Adm vs. S&P 500
Synergy Pharmaceuticals Inc vs. S&P 500
Bioject Medical Technologies Inc vs. S&P 500
US Airways Group Inc vs. S&P 500
Vanda Pharmaceuticals Inc vs. S&P 500
Antares Pharma Inc vs. S&P 500
American Realty Investors Inc vs. S&P 500
  

ColgatePalmolive Co

 
    
ColgatePalmo
Performance
0
Out Of
100
Over 30
Days
Over the last 30 days ColgatePalmolive Co has generated negative risk-adjusted returns adding no value to investors with long positions.
    

Match ups for ColgatePalmo

Procter Gamble Co vs. ColgatePalmolive Co
KimberlyClark Corporation vs. ColgatePalmolive Co
The Est vs. ColgatePalmolive Co
Avon Products Inc vs. ColgatePalmolive Co
Energizer Holdings Inc vs. ColgatePalmolive Co
Nu Skin Enterprises Inc vs. ColgatePalmolive Co
Elizabeth Arden Inc vs. ColgatePalmolive Co
Revlon Inc vs. ColgatePalmolive Co


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium